Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.000 AUD
792.13 K AUD
122.11 M AUD
317.54 M
About MEDADVISOR LIMITED
Sector
Industry
CEO
Richard Ratliff
Website
Headquarters
Camberwell
Founded
2010
ISIN
AU000000MDR6
FIGI
BBG001LRVJF2
MedAdvisor Ltd. engages in the provision of pharmacy-driven, innovative patient engagement solutions that simplify the patient medication journey to empower better health. It operates through the following segments: Australia and New Zealand Operations, the United States Operations, the United Kingdom Operations, Asia Operations, and Corporate. The company was founded by Joshua Swinnerton in 2010 and is headquartered in Camberwell, Australia.
AX.MDRHey investors!
here we have a tech. health stock with a deep retracement a defined long term downtrend. awaiting the reversal signals and taking note of the Fibonacci retracement. entry could be between 0.305 and 0.370 depending on how it react over the next week and possibly into Christmas, lower
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of MDR is 0.240 AUD — it has decreased by −4.00% in the past 24 hours. Watch MEDADVISOR LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange MEDADVISOR LIMITED stocks are traded under the ticker MDR.
MDR stock has fallen by −29.41% compared to the previous week, the month change is a −42.86% fall, over the last year MEDADVISOR LIMITED has showed a 33.33% increase.
We've gathered analysts' opinions on MEDADVISOR LIMITED future price: according to them, MDR price has a max estimate of 0.62 AUD and a min estimate of 0.45 AUD. Watch MDR chart and read a more detailed MEDADVISOR LIMITED stock forecast: see what analysts think of MEDADVISOR LIMITED and suggest that you do with its stocks.
MDR stock is 6.25% volatile and has beta coefficient of 0.67. Track MEDADVISOR LIMITED stock price on the chart and check out the list of the most volatile stocks — is MEDADVISOR LIMITED there?
Today MEDADVISOR LIMITED has the market capitalization of 137.83 M, it has increased by 2.94% over the last week.
Yes, you can track MEDADVISOR LIMITED financials in yearly and quarterly reports right on TradingView.
MEDADVISOR LIMITED is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
MDR earnings for the last half-year are −0.01 AUD per share, whereas the estimation was −0.01 AUD, resulting in a 9.09% surprise. The estimated earnings for the next half-year are 0.02 AUD per share. See more details about MEDADVISOR LIMITED earnings.
MEDADVISOR LIMITED revenue for the last half-year amounts to 46.60 M AUD, despite the estimated figure of 43.05 M AUD. In the next half-year revenue is expected to reach 79.55 M AUD.
MDR net income for the last half-year is −6.08 M AUD, while the previous report showed 6.87 M AUD of net income which accounts for −188.47% change. Track more MEDADVISOR LIMITED financial stats to get the full picture.
No, MDR doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MEDADVISOR LIMITED EBITDA is 6.89 M AUD, and current EBITDA margin is 5.64%. See more stats in MEDADVISOR LIMITED financial statements.
Like other stocks, MDR shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MEDADVISOR LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MEDADVISOR LIMITED technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MEDADVISOR LIMITED stock shows the strong sell signal. See more of MEDADVISOR LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.